3.4. NR5A1 Relates to Worse Outcomes in TCGA-ACC and ENSAT Cohorts. CENPA Has a Strong Association with Proliferation and Relates to a Bad Prognosis. This evidence concerns the gene NR5A1 and adrenal cortex carcinoma.